Physician profile
Allison Risley
NPI 1215403100
$1,297.39
in general payments reported to CMS, 2019-2025
11 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.15 · 2023: $125 · 2024: $572 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $328.57 | 2024-2025 | |
| Amgen INC. | $309.75 | 2024-2025 | Otezla, Otezla |
| Genzyme Corporation | $206.26 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $137.04 | 2024 | Sotyktu |
| Abbvie INC. | $124.53 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $71.84 | 2025 | Dupixent |
| Lilly USA, LLC | $32.77 | 2024 | Ebglyss, Taltz |
| Incyte Corporation | $27.40 | 2025 | Opzelura |
| Merz North America, INC. | $26.67 | 2025 | |
| Galderma Laboratories, L.P. | $18.15 | 2021 | |
| Biofrontera INC. | $14.41 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Risley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.